IPOs
By The Online Investor Staff, updated Tue., Oct. 15, 11:39 PM
| This Slide: #1 of 15 |
Slide #1. Vir Biotechnology, Inc. — Initial Public Offering
Company:
Vir Biotechnology, Inc.
Proposed Symbol:
VIR
Shares Offered:
7,142,858
Price Per Share:
$20.00
Over-Allotment:
1,071,428
Description:
Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, announced today that it has priced its initial public offering of 7,142,858 shares of its common stock at a public offering price of $20.00 per share. The gross proceeds to Vir, before deducting underwriting discounts, commissions and offering expenses, is expected to be approximately $142.9 million. All of the common stock is being offered by Vir. In addition, Vir has granted the underwriters a 30-day option to purchase up to 1,071,428 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions.
